ConductScience.org, home

Paper33767702

Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation.

Dhatchinamoorthy K and 2 others. Front Immunol, 2021. Cited by 863 papers, by iCite.

Cite this record

ConductScience Library. Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation. Papers, record 33767702. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33767702

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation.
PubMed
Journal
Front Immunol
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Review
PubMed
Citations, by iCite
863
iCite
Relative citation ratio, by iCite
48.1
iCite
Revised in PubMed
2023-02-02
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dhatchinamoorthy KKarthik
2Colbert JDJeff D
3Rock KLKenneth L

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigen PresentationMajor topic
Histocompatibility Antigens Class IMajor topic
NeoplasmsMajor topic
Tumor EscapeMajor topic
Animals
Gene Deletion
Gene Expression Regulation, Neoplastic
Humans
Killer Cells, Natural
Lymphocytes, Tumor-Infiltrating
Mutation
Signal Transduction
Transcription, Genetic
Tumor Microenvironment

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AI145932NIAID NIH HHSUnited StatesR01AI145932PubMed and NIHNIH RePORTER
R01 CA247624NCI NIH HHSUnited StatesR01CA247624PubMed and NIHNIH RePORTER
R01AI114495NIHNIH RePORTER

Download CSV of grants

References415

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131540894ALK and RET Inhibitors Promote HLA Class I Antigen Presentation and Unmask New Antigens within the Tumor Immunopeptidome.Cancer Immunol Res2019https://conductscience.org/library/papers/31540894PubMed
228187290Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy.Cell2017https://conductscience.org/library/papers/28187290PubMed
33259730Immunohistochemical analysis of tumor-infiltrating lymphocytes and major histocompatibility antigens in human gliomas and metastatic brain tumors.Surg Neurol1988https://conductscience.org/library/papers/3259730PubMed
428344889Loss of tapasin in human lung and colon cancer cells and escape from tumor-associated antigen-specific CTL recognition.Oncoimmunology2017https://conductscience.org/library/papers/28344889PubMed
525781678The transporter associated with antigen processing: a key player in adaptive immunity.Biol Chem2015https://conductscience.org/library/papers/25781678PubMed
68617293TAP1-deficient mice select a CD8+ T cell repertoire that displays both diversity and peptide specificity.Eur J Immunol1996https://conductscience.org/library/papers/8617293PubMed
729301958A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing.Science2018https://conductscience.org/library/papers/29301958PubMed
831413908TEIPP peptides: exploration of unTAPped cancer antigens.Oncoimmunology2019https://conductscience.org/library/papers/31413908PubMed
919883394Hypermethylation of HLA class I gene is associated with HLA class I down-regulation in human gastric cancer.Tissue Antigens2010https://conductscience.org/library/papers/19883394PubMed
1028161407A novel mutation in TAP1 gene leading to MHC class I deficiency: Report of two cases and review of the literature.Clin Immunol2017https://conductscience.org/library/papers/28161407PubMed
1112738726
Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation.
Clin Cancer Res2003https://conductscience.org/library/papers/12738726PubMed
1211970875Optimization of the MHC class I peptide cargo is dependent on tapasin.Immunity2002https://conductscience.org/library/papers/11970875PubMed
1311117911Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population.Lancet2000https://conductscience.org/library/papers/11117911PubMed
149421352Expression and prognostic significance of immunoregulatory molecules in esophageal cancer.Int J Cancer1997https://conductscience.org/library/papers/9421352PubMed
1528331615Nuclear IRF-1 expression as a mechanism to assess "Capability" to express PD-L1 and response to PD-1 therapy in metastatic melanoma.J Immunother Cancer2017https://conductscience.org/library/papers/28331615PubMed
1631358815Tumor intrinsic immunity related proteins may be novel tumor suppressors in some types of cancer.Sci Rep2019https://conductscience.org/library/papers/31358815PubMed
1721436444Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.Science2011https://conductscience.org/library/papers/21436444PubMed
188198988Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours.Br J Cancer1994https://conductscience.org/library/papers/8198988PubMed
193402430c-myc down-regulates class I HLA expression in human melanomas.EMBO J1988https://conductscience.org/library/papers/3402430PubMed
2012747744Concordant down-regulation of proto-oncogene PML and major histocompatibility antigen HLA class I expression in high-grade prostate cancer.Cancer Immun2003https://conductscience.org/library/papers/12747744PubMed

See all 415 referencesDownload CSV of references

Cited by679

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 863 citations.

PMIDTitleJournalYearIn PapersSource
42985562HLA class I and II polymorphisms in pediatric neuroblastoma: mechanistic links to immune surveillance, tumor evolution, and clinical translation.Front Genet2026https://conductscience.org/library/papers/42985562PubMed
42982877Deubiquitinases at the crossroads of T-cell immunity and tumor immune evasion.Cell Mol Immunol2026https://conductscience.org/library/papers/42982877PubMed
42926223CAR-NK cell immunotherapy: a comprehensive review of engineering platforms, clinical applications in hematological and solid tumors.J Cancer Res Clin Oncol2026https://conductscience.org/library/papers/42926223PubMed
42909179Mapping programmable mRNA research relevant to cancer-associated immune escape: a dual-database bibliometric and topic modeling analysis.Front Oncol2026https://conductscience.org/library/papers/42909179PubMed
42903663Towards epigenetically informed and biobank-driven precision immunotherapy in melanoma.Front Immunol2026https://conductscience.org/library/papers/42903663PubMed
42903418Molecular mechanisms and therapeutic strategies of immunotherapy resistance in esophageal cancer.Front Immunol2026https://conductscience.org/library/papers/42903418PubMed
42886326The haunted Umwelt: a biosemiotic and hauntological account of immune semiotic corruption in field cancerization.Theory Biosci2026https://conductscience.org/library/papers/42886326PubMed
42882506Antigen-Presentation Competence in Gynecologic Cancers: Mechanisms, Evidence and Translational Priorities.Cells2026https://conductscience.org/library/papers/42882506PubMed
42858644Integrative bulk and single-cell transcriptomics identifies a HERC5-linked immune-attenuated risk program for pulmonary metastasis/relapse in osteosarcoma.Transl Oncol2026https://conductscience.org/library/papers/42858644PubMed
42858555Inhibition of cellular NEDDylation partially alters the MHC class I immunopeptidome.J Immunol2026https://conductscience.org/library/papers/42858555PubMed
42835524AXL at the nexus of therapeutic resistance, tumor vascularization, and immune evasion in cancer.iScience2026https://conductscience.org/library/papers/42835524PubMed
42834086ATR inhibition induces NF-κB-dependent immunogenicity in Merkel cell carcinoma independent of cGAS-STING.NPJ Precis Oncol2026https://conductscience.org/library/papers/42834086PubMed
42819236A spatial-microbial-metabolic-immune framework for high-risk oral potentially malignant disorders: an evidence-ranked review for malignant transformation risk stratification.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42819236PubMed
42812989WWP2 in immune surveillance and antigen presentation: context-dependent roles in B cells, T cells, and tumor immune escape.Front Immunol2026https://conductscience.org/library/papers/42812989PubMed
42787254Beyond Structure: The Dynamic Role of the Extracellular Matrix Components in Immune Evasion.Cancer Commun (Lond)2026https://conductscience.org/library/papers/42787254PubMed
42786283Hepatitis B virus protein X promotes survival and loss of hepatocyte identity in a differentiated human liver organoid system.Cell Death Differ2026https://conductscience.org/library/papers/42786283PubMed
42781243Targeting the DNA Damage Response in Cancer.MedComm (2020)2026https://conductscience.org/library/papers/42781243PubMed
42774904Novel lipid nanoparticle in a mRNA cancer vaccine drives tumor control via type I IFNs and effector CD8+ T cells.Mol Ther Nucleic Acids2026https://conductscience.org/library/papers/42774904PubMed
42774728Beyond histocompatibility: human leukocyte antigen as a cross-disciplinary platform for immune recognition and clinical decision-making.Front Immunol2026https://conductscience.org/library/papers/42774728PubMed
42761714Lineage plasticity and immune invisibility in primary SCLC and LUAD-to-SCLC transformation: antigen presentation loss and therapeutic redirection.Front Immunol2026https://conductscience.org/library/papers/42761714PubMed

See all 679 cited byDownload CSV of cited by

Genes68

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALK238PubTator's text mininghttps://conductscience.org/library/genes/238NCBI Gene
ANPEP290PubTator's text mininghttps://conductscience.org/library/genes/290NCBI Gene
APLNR187PubTator's text mininghttps://conductscience.org/library/genes/187NCBI Gene
B2M567PubTator's text mininghttps://conductscience.org/library/genes/567NCBI Gene
B3GNT584002PubTator's text mininghttps://conductscience.org/library/genes/84002NCBI Gene
CALR811PubTator's text mininghttps://conductscience.org/library/genes/811NCBI Gene
CD22610666PubTator's text mininghttps://conductscience.org/library/genes/10666NCBI Gene
CD24451744PubTator's text mininghttps://conductscience.org/library/genes/51744NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
CXADRP1653108PubTator's text mininghttps://conductscience.org/library/genes/653108NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
EP3002033PubTator's text mininghttps://conductscience.org/library/genes/2033NCBI Gene
ERAP151752PubTator's text mininghttps://conductscience.org/library/genes/51752NCBI Gene
ERAP264167PubTator's text mininghttps://conductscience.org/library/genes/64167NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
EZH22146PubTator's text mininghttps://conductscience.org/library/genes/2146NCBI Gene
FAS355PubTator's text mininghttps://conductscience.org/library/genes/355NCBI Gene

See all 68 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33767702

GET https://conductscience.org/api/papers/v1/33767702/references?page=2